The aim of the call is to provide funding to companies developing and seeking to commercialize COVID-19 solutions that have reached the prototype stage, TRL 6 or higher.
Eligible applicants include companies and consortia of micro, small, and medium-sized enterprises operating in healthcare, medicine, biotechnology, pharmaceuticals, IT, robotics, automation, electronics, nanotechnology, and related fields.
Project topics include innovative diagnostics and image screening, protective equipment, sensors, and telemedicine devices.
Available funding is up to EUR 100,000, with 100% financing. Additional benefits include expert support on innovation development, market-related issues, access to infrastructure, and promotion through the organizers’ channels. Additional conditions apply regarding intellectual property.
Eligible costs include salaries, materials, inventory, travel expenses, service purchases, and 15% overhead costs.
Applications are accepted until April 30, 2021, 17:00 CET.
More information is available here. Applications can be submitted here.
